CNS Pharmaceuticals's market cap is currently $4.31M. The company's EPS TTM is $-75.019; its P/E ratio is ―; CNS Pharmaceuticals is scheduled to report earnings on April 7, 2025, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -4.13K	$ -11.76K	$ -13.07K	$ -11.10K	-
Operating Income	$ -18.87M	$ -15.27M	$ -14.03M	$ -9.45M	$ -3.83M
EBITDA	$ -18.86M	$ -15.26M	$ -14.47M	$ -9.44M	$ -3.83M
Net Income	$ -18.85M	$ -15.27M	$ -14.50M	$ -9.46M	$ -3.88M
Balance Sheet
Cash & Short-Term Investments	$ 548.72K	$ 10.06M	$ 5.00M	$ 14.04M	$ 7.24M
Total Assets	$ 1.70M	$ 13.05M	$ 8.76M	$ 15.85M	$ 7.91M
Total Debt	$ 300.81K	$ 409.97K	$ 387.79K	$ 439.29K	$ 0.00
Net Debt	$ -247.91K	$ -9.65M	$ -4.62M	$ -13.60M	$ -7.24M
Total Liabilities	$ 6.13M	$ 4.92M	$ 2.14M	$ 1.91M	$ 311.00K
Stockholders' Equity	$ -4.43M	$ 8.13M	$ 6.62M	$ 13.95M	$ 7.60M
Cash Flow
Free Cash Flow	$ -14.14M	$ -10.56M	$ -13.54M	$ -7.34M	$ -3.57M
Operating Cash Flow	$ -14.14M	$ -10.56M	$ -13.54M	$ -7.32M	$ -3.55M
Investing Cash Flow	$ -3.90K	$ -4.42K	$ -5.75K	$ -17.95K	$ -20.12K
Financing Cash Flow	$ 4.64M	$ 15.61M	$ 4.51M	$ 14.13M	$ 10.26M

Currency in USD

CNS Pharmaceuticals Earnings and Revenue History

Income Statement >

CNS Pharmaceuticals Debt to Assets

Balance Sheet >

CNS Pharmaceuticals Cash Flow

Cash Flow >

CNS Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing